Nadeem R. Abu‐rustum

Nadeem R. Abu‐rustum's AcademicInfluence.com Rankings

Medical

#2283

World Rank

#2696

Historical Rank

Gynecology

World Rank

Historical Rank

Oncology

#133

World Rank

#137

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Nadeem R. Abu‐rustum Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nadeem R. Abu‐rustum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (578)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. (2009) (529)
Endometrial cancer (2016) (486)
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. (2018) (456)
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC) (2006) (373)
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? (2007) (357)
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. (2006) (339)
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. (2012) (330)
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. (2006) (315)
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinoma (2006) (303)
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. (2004) (294)
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. (2017) (260)
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT). (2012) (254)
Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. (2014) (239)
Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging (2013) (204)
Gynecologic cancer treatment and the impact of cancer-related infertility. (2005) (200)
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? (2009) (199)
Cervical cancer, version 2.2015: Featured updates to the NCCN guidelines featured updates to the NCCN guidelines (2015) (197)
Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy. (2003) (190)
Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease (2007) (187)
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. (2012) (182)
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology (2007) (178)
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. (2014) (176)
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. (2008) (174)
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. (2016) (168)
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. (2009) (168)
Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. (2018) (168)
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups (2018) (163)
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. (2008) (162)
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. (2010) (162)
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. (2009) (159)
A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? (2004) (157)
Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. (2014) (157)
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. (2008) (154)
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. (2005) (153)
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. (2007) (152)
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. (2005) (147)
Cervical Cancer, Version 2.2015. (2015) (143)
Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. (2006) (140)
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. (2011) (139)
Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. (2016) (138)
Uterine neoplasms, version 1.2014. (2014) (136)
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. (2011) (136)
2017 Update on the Querleu–Morrow Classification of Radical Hysterectomy (2017) (135)
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? (2009) (132)
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. (2009) (132)
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. (2020) (130)
Cancer-Related Infertility in Survivorship (2009) (127)
Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. (2012) (121)
A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcoma (2012) (120)
A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. (2010) (120)
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. (2009) (119)
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems. (2009) (118)
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. (2008) (118)
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (112)
Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? (2008) (110)
New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. (2011) (109)
Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma (2016) (104)
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. (2010) (104)
Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis (2017) (103)
Cervical cancer. (2013) (102)
An International Series on Abdominal Radical Trachelectomy: 101 Patients and 28 Pregnancies (2012) (101)
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. (2014) (100)
Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. (2008) (100)
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. (2011) (99)
Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes. (2009) (99)
Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC) (2013) (96)
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. (2016) (92)
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients (2021) (91)
Risk factors for recurrence of ovarian borderline tumors. (2011) (91)
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. (2006) (90)
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. (2009) (89)
Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. (2007) (88)
Initial experience with Dargent's operation: the radical vaginal trachelectomy. (2008) (85)
Role of minimally invasive surgery in gynecologic cancers. (2006) (84)
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer (2018) (84)
Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees. (2013) (82)
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. (2017) (82)
Expanding the Indications for Radical Trachelectomy: A Report on 29 Patients With Stage IB1 Tumors Measuring 2 to 4 Centimeters (2013) (81)
REGRESSION OF UTERINE LOW‐GRADE SMOOTH‐MUSCLE TUMORS METASTATIC TO THE LUNG AFTER OOPHORECTOMY (1997) (80)
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. (2011) (80)
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping (2015) (80)
Sentinel lymph node biopsy in the management of gynecologic cancer (2015) (79)
Is endometrial carcinoma intrinsically more aggressive in elderly patients? (2003) (78)
Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. (2013) (78)
Subcutaneous Tumor Implantation After Laparoscopic Procedures in Women With Malignant Disease (2004) (77)
Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy. (2004) (75)
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. (2007) (75)
Sexual health needs and educational intervention preferences for women with cancer (2017) (75)
Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease. (2017) (74)
Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC) (2019) (73)
Comparing Surgical Outcomes in Obese Women Undergoing Laparotomy, Laparoscopy, or Laparotomy With Panniculectomy for the Staging of Uterine Malignancy (2007) (72)
Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. (2008) (71)
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion. (2013) (69)
Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study. (2006) (69)
Sentinel Lymph Node Mapping in Endometrial Cancer: An Update. (2016) (68)
Salvage weekly paclitaxel in recurrent ovarian cancer. (1997) (68)
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery (2015) (66)
The Revised 2009 FIGO Staging System for Endometrial Cancer: Should the 1988 FIGO Stages IA and IB Be Altered? (2010) (66)
Uterine Neoplasms. Clinical Practice Guidelines in Oncology. (2009) (66)
Second‐Look Operation for Epithelial Ovarian Cancer: Laparoscopy or Laparotomy? (1996) (65)
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. (2008) (65)
Radical trachelectomy for cervical cancer: postoperative physical and emotional adjustment concerns. (2008) (64)
Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. (1997) (64)
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. (2006) (63)
Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines. (2015) (63)
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer. (2015) (63)
Pelvic exenteration with curative intent for recurrent uterine malignancies. (2012) (62)
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. (2010) (62)
Update on sentinel node mapping in uterine cancer: 10‐year experience at Memorial Sloan–Kettering Cancer Center (2014) (62)
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. (2013) (62)
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer. (2018) (62)
Techniques of sentinel lymph node identification for early-stage cervical and uterine cancer. (2008) (61)
Pelvic lymphadenectomy in cervical cancer--surgical anatomy and proposal for a new classification system. (2010) (61)
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. (2012) (60)
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less. (2007) (60)
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. (2021) (60)
Cost-Effectiveness Analysis of Robotically Assisted Laparoscopy for Newly Diagnosed Uterine Cancers (2014) (59)
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. (2012) (58)
Persistent sexual arousal syndrome associated with increased soy intake. (2005) (58)
Transperitoneal laparoscopic pelvic and para-aortic lymph node dissection using the argon-beam coagulator and monopolar instruments: an 8-year study and description of technique. (2003) (58)
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer. (2012) (57)
Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy. (2007) (56)
Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study (2006) (56)
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer. (2013) (55)
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy? (2016) (55)
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma (2005) (54)
Lymphatic mapping in endometrial cancer: a literature review of current techniques and results (2007) (54)
Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation. (2013) (54)
Breast cancer metastatic to abdomen and pelvis: role of surgical resection. (2003) (54)
Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. (2001) (54)
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy. (2017) (53)
Fertility considerations in the management of gynecologic malignancies. (2011) (52)
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. (2009) (51)
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (51)
Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes. (2019) (51)
Cervical Conization and Sentinel Lymph Node Mapping in the Treatment of Stage I Cervical Cancer: Is Less Enough? (2013) (51)
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000–2013 (2017) (50)
The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. (2007) (50)
A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. (2016) (50)
The role of laparoscopy in second-look evaluations for ovarian cancer. (2001) (50)
Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation. (2010) (50)
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival? (2018) (48)
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk. (2010) (48)
Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (2009) (48)
Reproductive concerns of women treated with radical trachelectomy for cervical cancer. (2007) (48)
Role of imaging in the routine management of endometrial cancer (2018) (48)
Fertility-sparing surgery in early-stage cervical cancer: indications and applications. (2010) (48)
A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery. (2009) (47)
Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. (2005) (47)
Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma (2014) (47)
The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer. (2016) (47)
A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. (2013) (46)
Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care (2015) (46)
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger. (2011) (46)
The role of systemic chemotherapy in the management of granulosa cell tumors. (2015) (46)
Postoperative Pain Medication Requirements in Patients Undergoing Computer-Assisted (“Robotic”) and Standard Laparoscopic Procedures for Newly Diagnosed Endometrial Cancer (2013) (45)
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. (2018) (44)
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. (2008) (44)
The value of MR imaging when the site of uterine cancer origin is uncertain. (2011) (43)
Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping (2017) (43)
Molecular profiling and molecular classification of endometrioid ovarian carcinomas. (2019) (42)
Role of CT in the management of recurrent ovarian cancer. (2004) (42)
Metastatic breast carcinoma to the abdomen and pelvis. (1997) (42)
Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature. (2018) (41)
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma. (2010) (41)
The Increasing Credibility of Sentinel Lymph Node Mapping in Endometrial Cancer (2013) (40)
Management of malignant germ cell tumors of the ovary. (1998) (40)
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study (2021) (40)
Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer. (2009) (40)
Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life. (2016) (40)
Is It Time to Centralize Ovarian Cancer Care in the United States? (2016) (40)
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers (2021) (40)
The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. (2004) (39)
Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists (2019) (39)
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer (2016) (39)
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. (2008) (39)
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. (2010) (38)
NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update. (2020) (38)
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer. (2017) (38)
Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses. (2018) (37)
Prognostic Value of Lymph Node Ratio and Clinicopathologic Parameters in Patients Diagnosed With Stage IIIC Endometrial Cancer (2012) (37)
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer. (2013) (37)
Pediatric radical abdominal trachelectomy for cervical clear cell carcinoma: a novel surgical approach. (2005) (37)
Poor Compliance With Postmolar Surveillance and Treatment Protocols by Indigent Women (2000) (37)
Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors. (2010) (36)
Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract☆ (2016) (36)
Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer. (2009) (36)
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. (2016) (35)
Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future (2015) (35)
Accuracy of frozen section diagnosis of ovarian borderline tumor. (2011) (35)
Cytologic findings after fertility‐sparing radical trachelectomy (2007) (34)
Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. (2019) (34)
Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm. (2019) (33)
Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma. (2019) (33)
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer (2017) (33)
Fertility-sparing radical abdominal trachelectomy for cervical carcinoma. (2007) (32)
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases (2021) (32)
Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer. (2019) (31)
Options in the management of fertility-related issues after radical trachelectomy in patients with early cervical cancer. (2009) (31)
The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer. (2003) (31)
Micrometastasis of endometrial cancer to sentinel lymph nodes: is it an artifact of uterine manipulation? (2010) (31)
Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer. (2013) (31)
Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV. (2018) (31)
Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery. (2017) (30)
A new prognostic model for FIGO stage 1 epithelial ovarian cancer. (2007) (30)
Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system. (2008) (30)
Radical abdominal hysterectomy. (2001) (30)
Cervical cancer screening clinical practice guidelines in oncology. (2010) (29)
Breast cancer risk assessment in indigent women at a public hospital. (2001) (29)
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma? (2008) (29)
Ovarian and Uterine Disease in Women with Colorectal Cancer (1997) (29)
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity. (2013) (28)
Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. (2013) (28)
Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach. (2012) (28)
0126: Squamous Cell Carcinoma Arising in Mature Cystic Teratoma of the Ovary: a Case Series and Review of the Literature (2006) (28)
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes. (2017) (27)
Cervical Cancer , Version 3 . 2019 (2019) (27)
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary (2020) (27)
Incidence of Venous Thromboembolism After Minimally Invasive Surgery in Patients With Newly Diagnosed Endometrial Cancer (2012) (27)
Effect of a Predictive Model on Planned Surgical Duration Accuracy, Patient Wait Time, and Use of Presurgical Resources: A Randomized Clinical Trial. (2021) (26)
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer. (2019) (26)
Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy. (2006) (26)
Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review. (2020) (26)
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy. (2013) (25)
Risk‐reducing salpingectomy: Let us be opportunistic (2017) (25)
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. (2006) (25)
Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival. (2016) (25)
Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer. (2007) (24)
Brief report: Total pelvic exenteration‐A retrospective clinical needs assessment (2004) (24)
Pathologic Analysis of Ex Vivo Plasma Energy Tumor Destruction in Patients With Ovarian or Peritoneal Cancer (2010) (23)
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas (2021) (23)
Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical hysterectomy. (2009) (22)
Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat? (2018) (22)
Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management (2017) (22)
Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. (2008) (22)
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary (2020) (22)
Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects. (2019) (21)
Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma. (2014) (21)
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted? (2013) (21)
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies. (2009) (20)
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study (2020) (20)
Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer. (2008) (20)
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers (2020) (20)
Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment (2013) (20)
Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy. (2012) (20)
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer. (2012) (20)
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer (2021) (19)
Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma. (2020) (19)
Evolution and outcomes of sentinel lymph node mapping in vulvar cancer (2019) (19)
Transperitoneal laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic cancers (2006) (19)
DNA Mismatch Repair–deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas (2020) (19)
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer (2015) (19)
Grading Uterine Endometrioid Carcinoma: A Proposal That Binary Is Best (2014) (19)
Cervical cancer: Clinical practice guidelines in oncology (2013) (18)
Major hepatectomy at interval debulking for stage IV ovarian carcinoma: a case report. (2002) (18)
Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. (2018) (18)
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer. (2012) (18)
Recovery Issues of Fertility-Preserving Surgery in Patients With Early-Stage Cervical Cancer and a Model for Survivorship: The Physician Checklist (2010) (17)
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. (2006) (17)
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. (2009) (17)
Assessing disease extent in women with bulky or clinically evident metastatic cervical cancer: yield of pretreatment studies. (2000) (17)
A Prospective Randomized Trial Comparing Patient-Controlled Epidural Analgesia to Patient-Controlled Intravenous Analgesia on Postoperative Pain Control and Recovery After Major Open Gynecologic Cancer Surgery (2009) (17)
Management of cervical carcinoma diagnosed during pregnancy (2003) (17)
Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer. (2012) (17)
Genomic Landscape of Endometrial Carcinomas of No Specific Molecular Profile (2022) (16)
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. (2012) (16)
Clinical patterns and genomic profiling of recurrent ‘ultra-low risk’ endometrial cancer (2020) (16)
Innovative laparoscopic surgery in gynecologic oncology (2007) (16)
Cervical cancer. (2013) (16)
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma (2020) (15)
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas (2020) (15)
Ovarian cancer mutational processes drive site-specific immune evasion (2022) (15)
Location of Disease in Patients Who Die From Endometrial Cancer: A Study of 414 Patients From a Single Institution (2012) (15)
Long-Term Oncologic Outcomes of Uterine-Preserving Surgery in Young Women With Stage Ib1 Cervical Cancer (2018) (14)
Reconstructive techniques after diaphragm resection. (2009) (14)
A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer (2019) (14)
Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature. (2006) (14)
International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers (2015) (14)
Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. (2004) (14)
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma (2015) (14)
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family (2016) (13)
A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial) (2020) (13)
Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology. (2010) (13)
Uterine cancers: Clinical practice guidelines in oncology™ (2006) (13)
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative. (2020) (13)
Topotecan for recurrent cervical cancer after platinum-based therapy. (2000) (13)
Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes. (2021) (13)
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: A change in surgical approach (2004) (13)
Pediatric radical abdominal trachelectomy for solitary fibrous tumor of the uterine cervix. (2009) (13)
Early CA‐125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy (2007) (13)
Sentinel lymph node mapping in endometrial cancer – areas where further research is needed (2020) (13)
Radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy for early-stage cervical cancer in patients who desire to preserve fertility. (2007) (13)
Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer. (2004) (13)
Secondary surgical resection for patients with recurrent uterine leiomyosarcoma. (2018) (12)
Acute lower extremity paralysis following radiation therapy for cervical cancer. (1999) (12)
Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget's Disease of the Vulva. (2020) (12)
Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment (2021) (12)
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study (2022) (12)
Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection. (2004) (12)
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition (2021) (12)
Transperitoneal laparoscopic staging with aortic and pelvic lymph node dissection for gynecologic malignancies. (2007) (12)
Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancer. (2014) (11)
Cervical Cancers After Human Papillomavirus Vaccination (2009) (11)
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers (2020) (11)
Schauta radical vaginal hysterectomy. (2007) (11)
Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy. (2006) (11)
Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion. (2008) (11)
Complex Atypical Hyperplasia of the Uterus: Characteristics and Prediction of Underlying Carcinoma Risk (2011) (11)
Laparoscopy 2003: Oncologic Perspective (2003) (11)
Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. (2006) (11)
Invasive Stratified Mucinous Carcinoma (iSMC) of the Cervix Often Presents With High-risk Features That Are Determinants of Poor Outcome (2020) (11)
Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment. (2018) (11)
Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes (2020) (10)
Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial. (2021) (10)
Retroperitoneal lymph node dissection (RPLND). (2008) (10)
Epithelial ovarian cancer. (1999) (10)
The FILM Trial: A randomized phase III multicenter study assessing near infrared fluorescence in the identification of sentinel lymph nodes (SLN) (2018) (10)
Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors (2020) (10)
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. (2021) (10)
En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report. (2006) (10)
Characteristics and survival of cervical cancer patients managed at adjacent urban public and university medical centers. (2001) (10)
Robotic Surgery in the Frail Elderly: Analysis of Perioperative Outcomes (2020) (10)
Resection of recurrent cervical cancer after total pelvic exenteration (2006) (10)
Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy (2016) (10)
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer. (2012) (9)
Fifth International Conference on Ovarian Cancer: challenges and opportunities. (2005) (9)
Cervical cancer screening. (2014) (9)
Prospective Comparative Study of Laparoscopic Narrow Band Imaging (NBI) Versus Standard Imaging in Gynecologic Oncology (2018) (9)
Cervical cancer guidelines. Clinical practice guidelines in oncology. (2004) (9)
Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus (2016) (9)
Ligation of an anatomic variant of renal vasculature during laparoscopic periaortic lymph node dissection: a cause of postoperative renal infarction. (2003) (9)
Laparoscopic bilateral salpingo-oophorectomy in breast cancer patients after transverse rectus abdominus myocutaneous flap reconstructive surgery. (2005) (9)
FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers (2020) (9)
The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexa. (1999) (9)
Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center. (2018) (8)
Atlas of Procedures in Gynecologic Oncology (2003) (8)
Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma. (2006) (8)
Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm. (2021) (8)
Brain metastases in patients with low-grade endometrial carcinoma (2018) (8)
Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma. (2019) (8)
Risk Factors for Financial Toxicity in Gynecologic Cancer Patients. (2021) (8)
The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome. (2020) (8)
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus (2016) (7)
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer. (2016) (7)
Retroperitoneal lymph node dissection. (2007) (7)
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. (2021) (7)
Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study. (2020) (7)
Vulvar Cancer , Version 1 . 2017 Clinical Practice Guidelines in Oncology (2016) (7)
Increasing global accessibility to high-level treatments for cervical cancers. (2021) (7)
The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes. (2022) (7)
Post-recurrence survival in patients with cervical cancer. (2021) (7)
Radical Surgery With Individualized Postoperative Radiation for Stage IB Cervical Cancer: Oncologic Outcomes and Severe Complications (2013) (7)
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers. (2010) (7)
The Role of Laparoscopy in Second-Look Evaluations for Ovarian Cancer (2001) (7)
Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study (2020) (7)
Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort. (2021) (7)
Improving safety in robotic surgery: Intraoperative crisis checklist (2013) (6)
Presentation and Screening History of Indigent Women with Cervical Cancer: Implications for Prevention (2000) (6)
Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes (2021) (6)
Current role of therapeutic laparoscopy and thoracoscopy in the management of malignancy: a review of trends from a tertiary care cancer center. (2008) (6)
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer. (2021) (6)
Reproductive issues in the gynecologic cancer patient. (2007) (6)
594 Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study (2020) (6)
Uterine cancers. (2006) (6)
Cytoreductive surgery: abdominal retroperitoneum and adenopathy (2005) (6)
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer. (2020) (5)
Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer. (2017) (5)
Multicenter study assessing the detection of stage IIIC endometrial cancer in intermediate- and high-risk tumors between a contemporary sentinel node mapping versus historical comprehensive lymphadenectomy approach (2015) (5)
Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients With Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection (2018) (5)
Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis. (2021) (5)
The impact of near-infrared angiography and proctoscopy after rectosigmoid resection and anastomosis performed during surgeries for gynecologic malignancies. (2020) (5)
Local cervical recurrence after radical trachelectomy for early-stage cervical cancer: Is completion hysterectomy necessary? (2017) (5)
Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series. (2007) (5)
Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. (2014) (5)
Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women. (2021) (4)
Corrigendum to “Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy” [Gynecol. Oncol. 91 (2003) 402–409] (2004) (4)
Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer. (2021) (4)
Positron Lymphography via Intracervical 18F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies (2020) (4)
Sentinel lymph node identification for early-stage cervical cancer. (2007) (4)
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues. (2022) (4)
Radiation Therapy for Endometrial Cancer: An ASTRO Clinical Practice Guideline. (2022) (4)
CO(2) pneumoperitoneum or the Bookwalter: choose your access and exposure. (2005) (4)
The feasibility of mediastinal lymphadenectomy in the management of advanced and recurrent ovarian carcinoma (2011) (4)
Factors Associated With Use of a High-Volume Cancer Center by Black Women With Ovarian Cancer. (2019) (4)
The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists (2021) (4)
Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists (2021) (4)
Sentinel Lymph Node Mapping for Endometrial Cancer (2015) (4)
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines (2021) (4)
Improved overall survival for patients with advanced ovarian, tubal, and primary peritoneal carcinoma as a result of a change in surgical approach: A follow-up study (2007) (4)
A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen (2019) (3)
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower extremity lymphedema after sentinel lymph node mapping (SLNM) compared to lymphadenectomy (2018) (3)
Sentinel lymph node mapping: A valuable tool for assessing nodal metastasis in low grade endometrial cancer with superficial myoinvasion (2013) (3)
Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases (2021) (3)
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second‐look assessment (2008) (3)
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers. (2022) (3)
Surveillance patterns of cervical cancer patients treated with conization alone (2020) (3)
0014: Radical Vaginal Trachelectomy and Laparoscopic Pelvic Lymphadenectomy: an International Series (2006) (3)
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma (2021) (3)
Cancer of the cervix (2015) (3)
Factors Associated With Premature Ovarian Insufficiency in Young Women With Locally Advanced Rectal Cancer Treated With Pelvic Radiation Therapy (2021) (3)
An international series on abdominal trachelectomy: 101 patients and 28 pregnancies (2012) (3)
Intra-thoracic cytoreduction of stage IV peritoneal malignancy: a case series. (2008) (3)
Molecular classification of endometrial carcinomas: a singleinstitution review (084) (2022) (3)
ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment (2021) (3)
Prognostic signi fi cance of low volume sentinel lymph node disease in early-stage cervical cancer ☆ (2011) (3)
Prognostic impact of surgical nodal assessment in early-stage endometrioid carcinoma of the ovary: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013 (2017) (3)
Sentinel lymph node mapping for grade 1/2 endometrial cancer with superficial myoinvasion: Less is more (2011) (3)
Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome (2022) (3)
Pattern of disease and response to pembrolizumab in recurrent cervical cancer (2021) (3)
Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus (2015) (3)
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients (2020) (2)
Does treatment at a high volume center mitigate racial and ethnic disparities in ovarian cancer survival (2017) (2)
2022-RA-1057-ESGO Outcomes of gynaecological cancer surgery during the covid-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study (2022) (2)
Clinical Approach to Diagnosis and Management of Cancer of the Cervix and Vulva. (2011) (2)
In response to the comments of Dr. Giuseppe Del Priore (2007) (2)
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. (2023) (2)
Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma (2021) (2)
A call to standardize our approach to fertility-sparing surgery in patients with gynecologic cancers. (2017) (2)
Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management (2017) (2)
Feasibility of Adjuvant Chemotherapy After Pelvic Exenteration for Gynecologic Malignancies (2013) (2)
A phase 3 randomized controlled trial of preventive negative pressure wound therapy in postoperative incision management (2020) (2)
Superior pubic rami resection for isolated recurrent uterine cancer. (2007) (2)
Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma. (2022) (2)
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study. (2020) (2)
Paradigm shifts in gynecologic oncology (2021) (2)
Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma (2020) (2)
Screening for HIV infection in indigent women with newly diagnosed cervical cancer. (2001) (2)
26 The impact of using near-infrared angiography during rectosigmoid resection and anastampsis in patients undergoing gynecologic cancer surgery (2019) (2)
Endometrial carcinosarcoma (2022) (2)
Tailoring adjuvant treatment in patients with uterine cancer - Authors' reply. (2018) (2)
Risk prediction model for surgical site infections in patients undergoing open gynecologic cancer surgery following the implementation of a reduction bundle at a comprehensive cancer center (2018) (2)
Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system. (2022) (2)
Nanometastases of Endometrial Carcinoma to Sentinel Lymph Nodes: The Contribution of Pathologic Ultrastaging (2012) (2)
Comparison of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen (2018) (2)
Sentinel lymph node mapping in patients with vulvar malignancies using indocyanine green and near-infrared imaging: Preliminary detection rate experience (2015) (2)
Case report: Sentinel lymph node mapping of endometrial carcinoma occurring in uterine didelphys (2021) (2)
Does removal of a positive sentinel node without lymphadenectomy impact pelvic sidewall control in endometrial cancer (2014) (2)
Incidence of surgical site infection after implementation of a reduction bundle in gynecologic cancer patients undergoing colon surgery at a comprehensive cancer center (2017) (2)
Diagnosis and management of an endometrial cancer patient with Cowden syndrome. (2021) (2)
Sentinel lymph node mapping in patients with endometrial cancer undergoing robot-assisted or standard laparoscopic procedures (2011) (2)
Surgical postgraduate courses. Gynecologic oncology. Introduction. (2007) (1)
A multicenter prospective assessment of surgical findings associated with suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer (2015) (1)
Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma (2022) (1)
An analysis of the survival outcomes of video-assisted thoracic surgery in the primary management of patients with advanced ovarian, tubal, and peritoneal cancer (2014) (1)
Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? (2022) (1)
Unraveling the cause of death in endometrial cancer: A study of 2513 patients from a single institution (2012) (1)
Nomogram for predicting 5-year survival after primary surgery for epithelial ovarian cancer. (2009) (1)
The utility of sentinel lymph node biopsy in the surgical management of women with vulvar melanoma (2011) (1)
A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration. (2022) (1)
Patterns of Relapse in Patients With Endometrial Cancer Treated With Postoperative Intensity Modulated Radiation Therapy (IMRT) (2015) (1)
Impact of Postoperative Intensity Modulated Radiation Therapy (IMRT) on the Rate of Bowel Obstruction in Gynecologic Malignancy (2015) (1)
Cervical Cancer (2015) (1)
Costs of incorporating computer-based surgical platforms in the management of patients with newly diagnosed uterine cancers (2013) (1)
Expanding radical trachelectomy for cervical cancer with tumor ≥ 2 centimeters: A report of 29 cases (2012) (1)
Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping (2015) (1)
Cancer care affordability: what is our role? (2021) (1)
Evaluation of a novel classification of cervical adenocarcinoma to predict pelvic lymph node status in patients with early-stage cervical cancer (2019) (1)
Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform (2022) (1)
Vulvovaginal melanoma: An institutional experience (2013) (1)
Non-exenterative surgical management of recurrent endometrial carcinoma. (2021) (1)
Does operative start time impact the frequency of complete gross resection in patients undergoing primary cytoreduction for advanced serous ovarian carcinoma (2011) (1)
Oncologic outcomes of radical trachelectomy at a single institution (2011) (1)
Landscape of chromatin remodeling gene alterations in endometrial carcinoma. (2023) (1)
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center study. (2023) (1)
Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification. (2022) (1)
Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles. (2022) (1)
Multicenter study comparing two approaches to nodal assessment in patients with low-risk endometrial carcinoma: contemporary sentinel lymph node mapping versus historical selective systematic surgical staging (2015) (1)
Acquisition of APOBEC Mutagenesis and Microsatellite Instability Signatures in the Development of Brain Metastases in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma. (2020) (1)
When surgical innovation and payment systems collide: The sentinel lymph node story. (2019) (1)
A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer (2020) (1)
Patient-reported benefit from proposed interventions to reduce financial hardship during cancer treatment. (2020) (1)
Centralization of endometrial cancer care: Implications of preoperative subspecialty gynecologic pathology review (2017) (1)
Enhanced PAtient Clinical Streamlining (EPACS): Quality Initiative to Improve Healthcare for New Surgical Outpatient Visits (2022) (1)
Redefining stage I endometrial cancer: Incorporating histology, grade, myoinvasion, and whether or not lymph nodes were removed (2013) (1)
Classification system for pelvic lymphadenectomy in cervical cancer (2010) (1)
Outcomes in low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma (2015) (1)
Abstract 2553: Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes (2022) (1)
Germline risk assessment and genetic counseling in ovarian cancer patients of diverse self-reported race/ethnicity and ancestry (388) (2022) (1)
The second edition of the Society of Gynecologic Oncologists Surgical Postgraduate Courses supplement from the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa, Florida, USA, March 9-12, 2008. (2008) (1)
Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix (2022) (1)
Circulating cell-free DNA in patients with newly diagnosed and recurrent cervical cancer (2020) (1)
Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting (2022) (1)
Incidence of sentinel lymph node metastasis in endometrial carcinoma: Correlation with tumor grade and myometrial invasion (2012) (1)
Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer (2022) (1)
Cost-effectiveness analysis of robotically assisted radical hysterectomy for newly diagnosed uterine cervical cancer (2015) (1)
A survey of female cancer patients’ awareness of and preferences for receiving sexual health interventions (2014) (1)
Quantifying the Risk of Recurrence and Death in Stage III (FIGO 2009) Endometrial Cancer (2013) (1)
Use of immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract (2016) (1)
Overspending driven by dose-specific packaging of Lenvatinib for endometrial cancer (018) (2022) (1)
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study. (2020) (1)
Genomic determinants of early recurrences in low-stage low-grade endometrioid endometrial carcinoma. (2022) (1)
An international comparison of surgically staged patients with serous and clear cell endometrial carcinoma (2015) (1)
Is it time to centralize ovarian cancer care in the United States (2016) (1)
DNA mismatch repair protein defects and endometrial cancer in women age 40 and younger. (2009) (1)
O015/#502 Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes (2022) (1)
Outcomes of stage IA polyp-limited vs endometrium-limited epithelial high grade endometrial carcinoma (EMC). (2015) (0)
Postoperative pain medication requirements in patients undergoing robotically assisted and standard laparoscopic procedures for newly diagnosed endometrial cancer (2011) (0)
Classification of prospectively collected endometrial cancers into prognostically relevant subgroups using massively parallel sequencing and immunohistochemistry (2018) (0)
Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype. (2023) (0)
30 Evolution and outcomes of sentinel lymph node mapping in vulvar cancer (2019) (0)
Demographic shifts associated with implementation of evidence-based guidelines for ovarian conservation in patients with endometrioid endometrial cancer (2022) (0)
A Redefined Risk Stratification System for Patients With Stage I-II Myometrial Invasive Endometrioid Adenocarcinoma (2015) (0)
Annual cost of wasted indocyanine green during sentinel lymph node mapping for patients with endometrial cancer (2021) (0)
Reply to Markman (2007) (0)
Maximizing minimally invasive surgical approaches in the morbidly obese patient with newly diagnosed uterine cancer (2014) (0)
Intrauterine lavage as a novel method of detecting somatic mutations present in high-grade serous cancer of the ovary, fallopian tube or peritoneum (2020) (0)
Double-barrel wet colostomy is an acceptable alternative to separate bowel and urinary diversions in patients undergoing pelvic exenteration for gynecologic malignancies (2017) (0)
Reducing Disparities in Cervical Cancer Mortality Among Young Black Women. (2021) (0)
Neoadjuvant chemotherapy (NACT) selection for advanced stage ovarian cancer (AOC) at a comprehensive cancer center. (2015) (0)
Risk stratification of stage I grade 3 endometrioid endometrial carcinoma (083) (2022) (0)
Advances in the Treatment of Gynecologic Malignancies (2002) (0)
Outcomes of patients with stage I endometrial cancer in the sentinel lymph node era (2015) (0)
Cost-effectiveness analysis of conventional laparoscopic versus robotically assisted laparoscopic adnexal surgery for benign indications performed by gynecologic oncologists (2015) (0)
Molecular profiling of endometrioid ovarian carcinomas (2019) (0)
Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study (2022) (0)
EP299/#232 Genomic instability as a determinant of immune escape in ovarian cancer (2022) (0)
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation (2022) (0)
Indicated presurgical testing is a priority to achieve high-quality, cost-effective oncologic health care delivery (2018) (0)
Phase II study of adjuvant gemcitabine plus docetaxel (GD) for completely resected stage I-IV high grade uterine leiomyosarcoma (HGuLMS) (2007) (0)
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trial. (2022) (0)
36 Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in brca mutation carriers (2019) (0)
2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis (2022) (0)
Clinicopathologic characteristics of endometrial carcinoma metastatic to the ovary compared to endometrial carcinoma with synchronous ovarian carcinoma. (2017) (0)
Outcomes of surgery for stage IB cervical cancer: Variations between squamous and adenocarcinoma histology (2011) (0)
Collaborative Group of the Americas on Inherited Gastrointestinal Cancers (CGA-IGC) Annual Virtual Meeting, November 13–15, 2021 (2022) (0)
What Is the Role of Laparoscopic Surgery in Ovarian Cancer (2011) (0)
Predictors of Premature Ovarian Failure (POF) in Young Women with Locally Advanced Rectal Cancer (LARC) Treated with Pelvic Radiation Therapy (RT) (2020) (0)
Sentinel lymph node mapping for uterine cancer: A practical illustration of injection and mapping techniques (2014) (0)
Nodal selection during side-specific lymphadenectomy in cases of failed sentinel node mapping (2014) (0)
Outcome of early stage endometrial cancer in elderly patients (2002) (0)
An international collaboration for comparison of two approaches to surgical staging of low-risk endometrial cancer (2015) (0)
Comment on: En bloc resection of diaphragm with lung for recurrent ovarian cancer : A case report. Author's reply (2007) (0)
Outcomes of adjuvant platinum-based chemotherapy or radiation therapy in completely resected stage I-IV uterine carcinosarcoma (uCS) (2008) (0)
An international comparison of surgical staging approaches in patients with intermediate- and high-risk endometrioid endometrial cancer (2015) (0)
Evidence-based guidelines increase uptake and decrease racial disparities in endometrioid endometrial cancer patients electing ovarian preservation (573) (2022) (0)
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management. (2023) (0)
The amount of circulating cell-free DNA present in plasma of endometrial cancer patients is associated with surgical stage, histology and MRI-defined tumor volume (2019) (0)
Cervical Cancer ScreeningPractice Guidelines in Oncology (2010) (0)
Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing surgery for advanced ovarian cancer (2015) (0)
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy (2022) (0)
Radical hysterectomy: programmatic change to reduce laparotomy rate while maintaining oncologic outcome for early stage cervical cancer (2015) (0)
Lymph Node Involvement: Indicator or Instigator of Poor Outcome in Stage III Endometrial Cancer? (2012) (0)
Cold knife conization of the cervix (2013) (0)
Pelvic exenteration for recurrent vulvar squamous cell carcinoma (2016) (0)
DNA methylation-based classifier for diagnosis of endometrial cancer. (2018) (0)
High intermediate risk endometrioid endometrial carcinoma: Prognostic value of isolated tumor cells and role of adjuvant therapy (2019) (0)
Do stages I–II uterine clear cell carcinoma patients need to be treated as aggressively as patients with serous carcinoma? (2015) (0)
Reconstructive Af ter Diaphragm Resection (2009) (0)
Opening Scientific Plenary Session I (2017) (0)
Cystourethroscopy and ureteral catherization (2013) (0)
Clinical outcomes of patients with endometrioid ovarian cancer (2019) (0)
6) The Increasing Credibility of Sentinel Lymph Node Mapping in Endometrial Cancer(Clinical Trials for Lymphadenectomy in Endometrial Cancer in the Post-ASTEC/Post-SEPAL Era,Presidential Symposium dedicated to Professor Seiichiro Fujimoto) (2013) (0)
Lymphatic anatomy: lymphatics of the uterus (2022) (0)
Comparison of robot-assisted and standard laparoscopic procedures in patients with endometrial cancer (2011) (0)
Patterns of Relapse in Stage I-II Uterine Papillary Serous Carcinoma Treated With Adjuvant Intravaginal Radiation (IVRT) (2013) (0)
234 Clonality analysis of synchronous endometrial and ovarian carcinomas in patients with lynch syndrome (2019) (0)
Commentary (Konner/Abu-Rustum): Neoadjuvant Chemotherapy for Ovarian Cancer (2005) (0)
Outcomes of patients with uterine carcinosarcoma and low-volume lymph node metastases (2018) (0)
Performance on an independent elective rotation in gynecologic oncology is associated with improved gynecologic oncology fellowship match rates (2020) (0)
Role of lymphadenectomy and adjuvant treatment in high-risk endometrial cancer with positive lymph nodes: Comparison of a historical series with comprehensive surgical staging and a contemporary series with sentinel lymph nodes (2017) (0)
Surgical cytoreduction in stage IVB serous endometrial carcinoma (2019) (0)
Oncologists’ Attitudes Toward Cancer Care Affordability (2022) (0)
O016/#739 Outcomes of gynaecological cancer surgery during the COVID-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study (2022) (0)
The effect of accumulated minimally invasive surgical experience on endometrial cancer outcomes (2020) (0)
1055 : A Paradigm Shift in Treatment of Early-Stage Endometrial Cancer and its Effect on Outcome in Patients With Lymphovascular Invasion (2006) (0)
Implementation of Evidence-Based Presurgical Testing Guidelines in Patients Undergoing Ambulatory Surgery for Endometrial Cancer. (2021) (0)
The prognostic significance of white adipose tissue inflammation in advanced-stage, high-grade, and serous endometrial cancers. (2019) (0)
Serous tubal intraepithelial carcinoma (STIC) at the time of primary debulking surgery (PDS) of high-grade serous ovarian cancer (HGSOC): Does it matter? (2020) (0)
0012: Radical Trachelectomy for Endocervical Adenocarcinoma: Pitfalls of Frozen-Section Management (2006) (0)
Molecular profiling of ovarian germ cell tumors (2018) (0)
Resection of parenchymal liver metastases in patients with uterine malignancies (2019) (0)
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project. (2022) (0)
Intravaginal brachytherapy (IVRT) alone for patients with endometrial cancer meeting the PORTEC inclusion criteria (2007) (0)
Outcomes after recurrence of low-grade endometrial stromal sarcoma (LGESS) (150) (2022) (0)
Extent of lymphadenectomy in patients with node-positive (FIGO stage IIIC) endometrial carcinoma. (2011) (0)
A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer (2021) (0)
Utilization of an institutional algorithm for fertility preservation in young women with endometrial cancer (2016) (0)
Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma (2020) (0)
Genomic alterations in extramammary Paget’s disease of the vulva (2018) (0)
Prognosis of isolated tumor cells and the utility of molecular classification in early stage endometrioid endometrial cancer (243) (2022) (0)
Mismatch repair abnormalities are associated with aggressive tumor pathology in young women with endometrial cancer (2016) (0)
Iconographies supplémentaires de l'article : Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? (2011) (0)
Oncologic outcomes of “cut through” radical trachelectomy for early-stage cervical cancer (2011) (0)
Risk prediction model for surgical site infections in patients undergoing gynecologic cancer surgery (2016) (0)
Gynecologic tumor board (2015) (0)
With Thanks to the International Journal of Gynecological Cancer: Reviewers of 2011 (2011) (0)
Role of preoperative MRI in improving the selection of patients with early-stage cervical cancer for fertility-sparing surgery (2012) (0)
Laparoscopic intraperitoneal catheter placement (2013) (0)
Grand Rounds: Advances in laparoscopic tools for gynecologic surgery (2005) (0)
Outcomes in node-positive low-grade endometrioid endometrial carcinoma (2014) (0)
Use of near-infrared angiography during rectosigmoid resection and reanastomosis in women with gynecologic malignancies (2016) (0)
The role of surgery in high-risk gestational trophoblastic disease patients (2007) (0)
Cervical Cancer Screening Featured Updates (2014) (0)
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery (2016) (0)
Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage III squamous cell vulvar cancer (2016) (0)
A modern day experience with Brunschwig's operation: advancements in pelvic exenteration (2021) (0)
0141: Management of Morcellated Gynecologic Malignancies Incidentally Found On Final Pathology (2006) (0)
EP111/#458 Sectioning and extensively examining the fimbriated end of fallopian tubes for endometrial cancer (2022) (0)
Fertility-sparing surgery in stage IA2 cervical cancer: Associated factors and long-term survival. (2016) (0)
Long-term oncologic outcomes of fertility-sparing surgery in young women with stage IB1 cervical cancer. (2016) (0)
Automated patient-reported symptom data capture, tracking, and intervention during recovery from ambulatory gynecologic cancer surgery: A prospective study (2017) (0)
Conservative management of cervical cancer in pregnancy (2019) (0)
Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high-grade on preoperative biopsy and low-grade on hysterectomy specimen (2017) (0)
A preoperative tool for estimating the risk of blood transfusion over an ovarian cancer debulking surgery (113) (2022) (0)
Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab. (2020) (0)
Stage IA2 cervical cancer: Long-term outcomes with less radical as opposed to more radical surgical management. (2016) (0)
ConCerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer, by Schmeler et al (2021) (0)
Gastric-type adenocarcinoma of the cervix: Genomic drivers and clinical outcomes. (2020) (0)
Identification of endometrial cancer mutations in pelvic washings using massively parallel sequencing: A pilot study (2020) (0)
CASE REPORT Major Hepatectomy at Interval Debulking for Stage IV Ovarian Carcinoma: A Case Report (2002) (0)
Endometrial cancers in or germline mutations carriers (2019) (0)
Reduction in unnecessary postoperative opioid prescription among patients undergoing inpatient gynecologic surgery by standardizing postoperative prescribing practices (499) (2022) (0)
40 Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma (2019) (0)
Factors associated with the access and use of a high-volume cancer center by black women with ovarian cancer: A qualitative study (2018) (0)
Response to Drs. Gordon and Schimp (2010) (0)
Gynecologic Tumor Board: Clinical Cases in Diagnosis and Management of Cancer of the Female Reproductive System (2008) (0)
Clinical outcome of Serous Tubal Intraepithelial Carcinomas (STIC) (2012) (0)
Non-exenterative surgical management of recurrent endometrial carcinoma: patient characteristics and outcomes (2021) (0)
Impact of postoperative chemotherapy in patients with comprehensively staged uterine serous carcinoma (2019) (0)
Quaternary and beyond cytoreduction: An updated and expanded analysis (2021) (0)
Use of a dedicated radiologic assessment score to individualize the management of women with primary advanced epithelial ovarian cancer: A triage tool to optimize outcomes and minimize interventions (2020) (0)
31 Surgical cytoreduction in advanced stage serous endometrial carcinoma (2019) (0)
Epidural anesthesia is associated with improved overall survival in patients undergoing primary debulking surgery for ovarian cancer (2018) (0)
Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management (100) (2022) (0)
Comparison of Early-Stage Uterine Papillary Serous Carcinoma (UPSC) and Carcinosarcoma Treated With Adjuvant Carboplatin/Taxane Chemotherapy and Intravaginal Radiation Therapy (IVRT) (2014) (0)
Postoperative IMRT for Cervical and Endometrial Cancer (2011) (0)
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary (2020) (0)
112 Pediatric abdominal trachelectomy for rhabdomyosarcoma (2019) (0)
Association between neoadjuvant chemotherapy response and survival outcomes in patients undergoing interval cytoreduction for advanced ovarian cancer (2012) (0)
Utilization of specialized postoperative services in a comprehensive surgical cytoreduction program (2011) (0)
Uterine carcinosarcomas and metaplastic breast carcinomas: Genetically related cancers? (2020) (0)
Effect of pelvic exenteration type and vaginal reconstruction on quality of life. (2010) (0)
A preoperative algorithm for the management of primary ovarian cancer: A process and outcome evaluation (2017) (0)
Are All High-Intermediate Risk Early Stage Endometrioid Carcinomas of the Uterus Created Equal? (2018) (0)
Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification (2022) (0)
Surgical ovarian ablation for hormone receptor positive primary breast cancer in premenopausal women. (2017) (0)
Risk factors for financial toxicity in gynecologic cancer patients receiving treatment (2020) (0)
Feasibility of assessing wound perfusion at the time of laparotomy closure (2020) (0)
What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both? (542) (2022) (0)
Impact of adjuvant therapy on oncologic outcomes in early-stage uterine clear cell carcinoma (2020) (0)
Primary debulking surgery for advanced ovarian cancer: The Kaizen approach to continued improvement in surgical outcomes (2017) (0)
Combined preoperative and extended pharmacologic venous thromboembolic prophylaxis in patient undergoing surgery for advanced adnexal malignancies (2015) (0)
Prophylactic oophorectomy in premenopausal women with non-metastatic colon cancer: A decision analysis. (2006) (0)
Detection of sentinel lymph nodes using indocyanine green and near-in- frared fluorescence imaging for gynecological malignancies (2013) (0)
Clinical impact of major discrepancies in pathology reports of gynecologic malignancies (2020) (0)
The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer. (2018) (0)
Severe complications and oncologic outcome of stage IB cervical cancer treated with radical surgery and individualized post-operative radiation (2012) (0)
Multi gene panel testing in unselected patients (pts) with endometrial cancer (EC). (2017) (0)
The development and implementation of a gynecologic cancer survivorship tool. (2019) (0)
Impact of adjuvant chemotherapy in patients with FIGO stage I endometrioid ovarian carcinoma in the platinum era: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013 (2017) (0)
Near-Infrared angiography during rectosigmoid resection and anastomosis in women with gynecologic malignancies (2018) (0)
The impact of intraoperative tumor fragmentation or morcellation in patients with early-stage uterine leiomyosarcoma (2015) (0)
Impact of adjuvant chemotherapy in patients with FIGO stage I ovarian clear cell cancer in the platinum era: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013 (2017) (0)
Isolated vaginal recurrences in women with stage I endometrial cancer (2021) (0)
0056: Surgical Removal of Pelvic Lymph Nodes Influences Endometrial Cancer Outcomes: an 11-Year Study (2006) (0)
Does minimally invasive surgery compromise the oncologic outcome of women with high-risk non-endometrioid endometrial carcinomas (2014) (0)
Acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: Experience of clinical outcome in a prospective trial (2020) (0)
Comparison of minimally invasive and open surgical approach in the treatment of uterine carcinosarcoma (2020) (0)
Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes (2022) (0)
Robotic radical hysterectomy: Extent of tumor resection and operative outcomes compared with laparoscopy and exploratory laparotomy (2011) (0)
Somatic tumor profiling of DNA mismatch repair (MMR) deficient endometrial cancers (EC). (2017) (0)
Implementation of evidence-based pre-surgical testing guidelines in patients undergoing surgery for endometrial cancer (2019) (0)
ASO Author Reflections: Narrow-Band Imaging: A Novel Imaging Method in Minimally Invasive Surgery (2018) (0)
Novel diagnostic and therapeutic approaches in Gynecologic Oncology: considerations for a new decade. (2011) (0)
Nezhat's Operative Gynecologic Laparoscopy and Hysteroscopy: GYNECOLOGIC MALIGNANCY (2008) (0)
High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer. (2022) (0)
Risk Stratification of Death From Endometrial Cancer in Patients With Early Stage Disease (2007) (0)
Does para-aortic lymph node assessment during endometrial cancer staging impact overall survival? (2013) (0)
The impact of bowel preparation on surgical site infection rates in gynecologic oncology surgery, post-hoc analysis from a randomized controlled trial (550) (2022) (0)
Commentary (Are/Abu-Rustum)—Laparoscopic Surgery for Cancer: Historical, Theoretical, and Technical Considerations (2006) (0)
Molecular and pathologic data can guide selection of endometrioid endometrial cancer patients for ovarian preservation (239) (2022) (0)
013 The Development and Implementation of a Gynecologic Cancer Survivorship Tool (2020) (0)
Urologic outcomes following modified Indiana pouch during pelvic exenteration for gynecologic malignancies (2013) (0)
100 Questions and Answers about Ovarian Cancer (2004) (0)
Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors. (2022) (0)
Combined modality adjuvant therapy for FIGO stage IIIC endometrial carcinomas (2014) (0)
Clinical outcomes of patients with endometrioid epithelial ovarian cancer following surgical treatment (2021) (0)
Electronic symptom monitoring with patient-reported outcomes in patients recovering from ambulatory minimally invasive gynecologic cancer surgery: A prospective pilot study (2019) (0)
Risk of new breast and ovarian cancers and utility of incremental genetic testing in a high-risk BRCA negative cohort (2018) (0)
Herniation formation in women undergoing surgery for endometrial cancer (2016) (0)
Cell-free DNA analysis as a molecular tool to monitor response to immune checkpoint inhibition in endometrial cancer. (2022) (0)
0735: Laparoscopic Staging of Previously Unstaged Endometrial Cancer (2006) (0)
Progress in surgical oncology: Gynecology perspective (2022) (0)
Germline drivers of gynecologic carcinosarcomas (2023) (0)
Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy (2006) (0)
Minimal access surgery compared with laparotomy for secondary cytoreduction in patients with recurrent ovarian carcinomas (2016) (0)
2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study (2022) (0)
O036/#221 Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer – going to the next level: a memorial sloan kettering team ovary study (2022) (0)
Paper 5: The Safety and Efficacy of Laparoscopic Surgical Staging of Apparent Stage I Ovarian and Fallopian Tube Cancers (2004) (0)
Sentinel lymph node biopsy compared with systematic lymphadenectomy in patients with uterine carcinosarcoma (536) (2022) (0)
Use of indocyanine green for sentinel lymph node biopsy in patients with iodine or contrast allergy (2021) (0)
Comprar Atlas of Procedures in Gynecologic Oncology, Second Edition | Douglas A. Levine | 9781841844985 | Informa Healthcare (2008) (0)
Sentinel lymph node biopsy of the endometrium (2022) (0)
Surgery at a high-volume center reduces the impact of income on survival for women with advanced ovarian cancer (2017) (0)
Prospective study evaluating white adipose tissue inflammation and clinicopathologic features in endometrial cancer (2019) (0)
Compositional and architectural characterization of high-grade serous ovarian carcinomas using single cell technologies and multiplex microscopy (2020) (0)
0079: Maximal Surgical Cytoreduction Increases Sensitivity to Platinum-Taxane Chemotherapy in Patients with Advanced Ovarian Cancer (2006) (0)
The changing clinical features of cervical adenocarcinoma: Increasing proportion but favorable oncologic outcome (2012) (0)
Sentinel lymph node mapping for apparent early-stage uterine cancer (2014) (0)
PO-252 ADJUVANT CARBOPLATIN/PACLITAXEL AND INTRAVAGINAL RADIATION FOR STAGE I-II SEROUS ENDOMETRIAL CANCER (2012) (0)
Abstract 1692: Single-cell DNA sequencing from frozen endometrial tumors to address clonal evolution of somatic mutations (2022) (0)
Correlation between preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma and final hysterectomy pathology (2008) (0)
O017/#479 Germline pathogenic variants in DNA repair genes and endometrial cancer risk (2022) (0)
Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? (117) (2022) (0)
Utility of “reflex” CT scans during surveillance of serous ovarian cancer (2012) (0)
Comprehensive Analysis of Germline Drivers in Endometrial Cancer. (2023) (0)
The Kooby article reviewed (2006) (0)
Clinical, Morphologic, and Molecular Features Associated With Ovarian Metastases From Pattern A Endocervical Adenocarcinomas (2021) (0)
Sentinal lymph node identification for early-stage cervical and uterine cancer (2008) (0)
The role of surgical intervention in the treatment of rhabdomyosarcoma of the uterine corpus or cervix among teens and young adults, specifically from a fertility-sparing perspective (2020) (0)
Impact of carcinoma involving adenomyosis on the survival of patients with endometrial endometrioid adenocarcinoma (2016) (0)
Sentinel lymph node mapping for early-stage cervical cancer: A single institution's experience (2016) (0)
The significance of positive peritoneal cytology in stage III endometrial cancer (2013) (0)
Multicenter study comparing oncologic outcomes in patients with serous and clear cell endometrial carcinoma between two nodal assessment methods: A sentinel lymph node algorithm vs a comprehensive pelvic and para-aortic lymphadenectomy (2017) (0)
Mutation detection in cell-free DNA using ultra-high depth sequencing in prospectively collected newly diagnosed endometrial cancer patients (2020) (0)
Topotecan in Combination With Cisplatin for the Treatment of Stage IVB, Recurrent, or Persistent Cervical Cancer: Review 2 (2006) (0)
The potential for reporting bias in the upfront treatment of ovarian cancer and the continued case for ‘denominator data’: An MSK team ovary project (2018) (0)
Impact of lymph node ratio and clinico-pathologic parameters on stage IIIC endometrial cancer prognosis: A validation study (2012) (0)
Impact of sentinel lymph node mapping algorithm on identification of stage IIIC endometrial cancer (2012) (0)
Genetic Discoveries and Pathologic Variations in Ovarian Cancer Moderators: Charles Landen, MD, and Barbara Norquist, MD May 22, 3:30 p.m. CST Histopathological characterization of the tubal fimbria reveals a subgroup of BRCA1 mutation carriers with tumor- promoting gene-set enrichment (2020) (0)
Patterns of recurrence and associated clinical factors in patients with advanced serous ovarian cancer who experience a CA125 negative recurrence (2012) (0)
Predicting overall survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer: a prognostic nomogram (2014) (0)
ASO Visual Abstract: Enhanced PAtient Clinical Streamlining (EPACS)—Quality Initiative to Improve Healthcare for New Surgical Outpatient Visits (2022) (0)
2022-RA-426-ESGO Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: subgroup analysis of the SCCAN project (2022) (0)
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study. (2023) (0)
Removal of positive pelvic sentinel lymph nodes without additional lymphadenectomy does not compromise pelvic side wall control in patients with endometrial cancer (2019) (0)
Incremental value of Tc-99m sulphur colloid SPECT-CT imaging in sentinel node mapping in endometrial cancer (2009) (0)
Gynecologic malignancy: Port-site metastasis and pneumoperitoneum (2008) (0)

This paper list is powered by the following services:

Nadeem R. Abu‐rustum's Academic­Influence.com Rankings

Why Is Nadeem R. Abu‐rustum Influential?

Nadeem R. Abu‐rustum's Published Works

Published Works

Nadeem R. Abu‐rustum's AcademicInfluence.com Rankings